Klaus Überla
- Virology top 0.2%
- HIV Research and Treatment 74
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research 29
- HIV/AIDS drug development and treatment 18
- Immunology top 1%
- Immunotherapy and Immune Responses 38
- Immune Cell Function and Interaction 31
- T-cell and B-cell Immunology 20
- Animal Science and Zoology top 1%
- Epidemiology top 2%
-
- Virus-based gene therapy research 31
-
- RNA Interference and Gene Delivery 19
- Co-authors
- Ibrahim Ahmed HamzaLars JurzikMichael WilhelmVladimir TemchuraThomas GrünwaldTibor DiamantsteinThomas BlankensteinSeraphin Kuate
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Klaus Überla
194 papers receiving 6.1k citations
Peers
Comparison fields: 5 of 147
- Virology 1.6k
- Infectious Diseases 2.3k
- Immunology 2.0k
- Animal Science and Zoology 403
- Epidemiology 1.3k
Countries citing papers authored by Klaus Überla
This map shows the geographic impact of Klaus Überla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Überla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Überla more than expected).
Fields of papers citing papers by Klaus Überla
This network shows the impact of papers produced by Klaus Überla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Überla. The network helps show where Klaus Überla may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Klaus Überla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 16 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 10 | |
| 8 | 2022 | 9 | |
| 9 | 2022 | 11 | |
| 10 | 2021 | 11 | |
| 11 | 2020 | 5 | |
| 12 | 2020 | 15 | |
| 13 | 2020 | 12 | |
| 14 | 2019 | 18 | |
| 15 | 2019 | 13 | |
| 16 | 2018 | 29 | |
| 17 | 2017 | 15 | |
| 18 | 2016 | 34 | |
| 19 | 2014 | 13 | |
| 20 | 2009 | 30 |
About Klaus Überla
Klaus Überla is a scholar working on Virology, Infectious Diseases, Immunology, Epidemiology and Genetics, having authored 199 papers that have together received 6.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (74 papers), Immunotherapy and Immune Responses (38 papers), Immune Cell Function and Interaction (31 papers), Virus-based gene therapy research (31 papers), SARS-CoV-2 and COVID-19 Research (29 papers), T-cell and B-cell Immunology (20 papers), RNA Interference and Gene Delivery (19 papers) and HIV/AIDS drug development and treatment (18 papers). The work is most often cited by research in Virology (1.6k citations), Infectious Diseases (2.3k citations), Immunology (2.0k citations), Animal Science and Zoology (403 citations) and Epidemiology (1.3k citations). Klaus Überla has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Ibrahim Ahmed Hamza, Lars Jurzik, Michael Wilhelm, Vladimir Temchura, Thomas Grünwald, Tibor Diamantstein, Thomas Blankenstein, Seraphin Kuate, Matthias Tenbusch and Alexander Stang. Their work appears in journals such as Journal of Virology, Vaccine, Retrovirology, PLoS ONE and Journal of General Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.